- Home
- Publications
- Publication Search
- Publication Details
Title
Update on Typical and Atypical Antipsychotic Drugs
Authors
Keywords
-
Journal
Annual Review of Medicine
Volume 64, Issue 1, Pages 393-406
Publisher
Annual Reviews
Online
2012-10-01
DOI
10.1146/annurev-med-050911-161504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clozapine is gold standard, but questions remain
- (2012) Jan Volavka INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day
- (2012) Herbert Y. Meltzer et al. SCHIZOPHRENIA RESEARCH
- Treatment of substance abusing patients with comorbid psychiatric disorders
- (2011) Thomas M. Kelly et al. ADDICTIVE BEHAVIORS
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Risk of Mortality Among Individual Antipsychotics in Patients With Dementia
- (2011) Helen C. Kales et al. AMERICAN JOURNAL OF PSYCHIATRY
- Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial
- (2011) Eirik Kjelby et al. BMC Psychiatry
- Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults
- (2011) Alicia Ruelaz Maher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mid-Term and Long-Term Efficacy and Effectiveness of Antipsychotic Medications for Schizophrenia
- (2011) Ira D. Glick et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dopamine D2 Receptor Occupancy and Clinical Effects
- (2011) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Iloperidone, Asenapine, and Lurasidone: A Brief Overview of 3 New Second-Generation Antipsychotics
- (2011) Leslie Citrome POSTGRADUATE MEDICINE
- Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
- (2011) Adrian Newman-Tancredi et al. PSYCHOPHARMACOLOGY
- The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment
- (2011) Herbert Y. Meltzer et al. PSYCHOPHARMACOLOGY
- A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics
- (2010) Alessandro Serretti et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Past and Present Progress in the Pharmacologic Treatment of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs
- (2010) Mehrul Hasnain et al. JOURNAL OF PSYCHOPHARMACOLOGY
- What Have We Learned about Trial Design From NIMH-Funded Pragmatic Trials?
- (2010) John March et al. NEUROPSYCHOPHARMACOLOGY
- Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
- (2010) Joanna C. Neill et al. PHARMACOLOGY & THERAPEUTICS
- A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia
- (2010) Herbert Y. Meltzer et al. PSYCHIATRY RESEARCH
- Clinical Trials Design Lessons From the CATIE Study
- (2009) Helena Chmura Kraemer et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Cognitive Cost of Anticholinergic Burden: Decreased Response to Cognitive Training in Schizophrenia
- (2009) Sophia Vinogradov et al. AMERICAN JOURNAL OF PSYCHIATRY
- Improving Quality And Diffusing Best Practices: The Case Of Schizophrenia
- (2009) Marcela Horvitz-Lennon et al. HEALTH AFFAIRS
- Comparative Effectiveness Research For Antipsychotic Medications: How Much Is Enough?
- (2009) David O. Meltzer et al. HEALTH AFFAIRS
- Adjunctive α2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission
- (2009) Monica M. Marcus et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia
- (2009) Herbert Y. Meltzer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Standard and Higher Dose of Olanzapine in Patients With Schizophrenia or Schizoaffective Disorder
- (2009) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Mortality Rates Among Patients With Schizophrenia and Tardive Dyskinesia
- (2009) Siow-Ann Chong et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
- Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
- (2009) Herbert Y Meltzer et al. NEUROPSYCHOPHARMACOLOGY
- An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia
- (2009) Sarah K. Keedy et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
- (2009) Atheir I. Abbas et al. PSYCHOPHARMACOLOGY
- CATIE and CUtLASS: can we handle the truth?
- (2008) Shôn Lewis et al. BRITISH JOURNAL OF PSYCHIATRY
- Extrapyramidal side-effects of antipsychotics in a randomised trial
- (2008) Del D. Miller et al. BRITISH JOURNAL OF PSYCHIATRY
- Addressing cardiometabolic risk during treatment with antipsychotic medications
- (2008) Jonathan M Amiel et al. CURRENT OPINION IN PSYCHIATRY
- Discovery of a New Class of Potential Multifunctional Atypical Antipsychotic Agents Targeting Dopamine D3and Serotonin 5-HT1Aand 5-HT2AReceptors: Design, Synthesis, and Effects on Behavior
- (2008) Stefania Butini et al. JOURNAL OF MEDICINAL CHEMISTRY
- A review of the association between antipsychotic use and hyperprolactinaemia
- (2008) Chris Bushe et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- The spurious advance of antipsychotic drug therapy
- (2008) Peter Tyrer et al. LANCET
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- Antipsychotic-Induced Hyperprolactinemia
- (2008) Jolene R Bostwick et al. PHARMACOTHERAPY
- Second-Generation Antipsychotics: Cost-Effectiveness, Policy Options, and Political Decision Making
- (2008) R. A. Rosenheck et al. PSYCHIATRIC SERVICES
- A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment
- (2008) Philip D. Harvey et al. SCHIZOPHRENIA RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started